Clinical Trial Update: Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating SB-497115 in healthy subjects and subjects with varying renal function to characterize safety and pharmacokinetics, in the context of i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura

Drugs mentioned

• SB-497115

Snippet

Sponsor: GlaxoSmithKline | Conditions: Purpura, Thrombocytopaenic, Idiopathic | Phase 1 | Status: COMPLETED